Activation of GPR119 by fatty acid agonists augments insulin release from clonal β-cells and isolated pancreatic islets and improves glucose tolerance in mice

References

Bailey, C.J. and Flatt, P.R. (1982). Influence of genetic background and age on the expression of the obese hyperglycaemic syndrome in Aston ob/ob mice. Int. J. Obesity 6, 11–21.Suche in Google Scholar

Chu, Z.L., Jones, R.M., He, H., Carroll, C., Gutierrez, V., Lucman, A., Moloney, M., Gao, H., Mondala, H., Bagnol, D., et al. (2007). A role for β-cell-expressed G protein-coupled receptor 119 in glycaemic control by enhancing glucose-dependent insulin release. Endocrinology 148, 2601–2609.Suche in Google Scholar

Chu, Z., Carroll, C., Alfonso, J., Gutierrez, V., He, H., Lucman, A., Pedraza, M., Mondala, H., Gao, H., Bagnol, D., et al. (2008). A role for intestinal endocrine cell-expressed G protein-coupled receptor 119 in glycaemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release. Endocrinology 149, 2038–2047.Suche in Google Scholar

Cox, H.M., Tough, I.R., Woolston, A.M., Zhang, L., Nguyen, A.M., Sainsbury, A. and Herzog, H. (2010). Peptide YY is critical for acylethanolamide receptor GPR119-induced activation of gastrointestinal mucosal responses. Cell Metab. 11, 532–542.Suche in Google Scholar

Flatt, P.R. and Bailey, C.J. (1981). Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice. Diabetologia 20, 573–577.Suche in Google Scholar

Flock, G., Holland, D., Seino, Y. and Drucker, D.J. (2011). GPR119 regulates murine glucose homeostasis through incretin receptor-dependent and independent mechanisms. Endocrinology 152, 374–383.Suche in Google Scholar

Fyfe, M.T.C., McCormack, J.G., Overton, H.A., Procter, M.J. and Reynet, C. (2008). GPR119 agonists as potential new oral agents for the treatment of type 2 diabetes and obesity. Expert Opin. Drug Discov. 3, 403–413.Suche in Google Scholar

Godlewski, G., Offertaler, L., Wagner, J.A. and Kunos, G. (2009). Receptors for acylethanolamides- GPR55 and GPR119. Prostaglandins Other Lipid Mediat. 89, 105–111.Suche in Google Scholar

Hansen, K.B., Rosenkilde, M.M., Knop, F.K., Wellner, N., Diep, T.A., Rehfeld, J.F., Anderson, J.B., Holst, J.J., and Hansen, H.S. (2011). 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans. J. Clin. Endocrinol. Metab. 96, E1409–E1417.Suche in Google Scholar

Katz, L.B., Gamable, J.J., Rothenberg, P.L., Vanapalli, S.R., Vaccaro, N., Xi, L., Polidori, D.C., Vets, E., Sarich, T.C., and Stein, P.P. (2011). Pharmacokinetics, Pharmacodynamics, safety and tolerability of JNJ-38431055, a novel GPR119 receptor agonist and potential antidiabetes agent, in healthy male subjects. Clin. Pharmacol. Ther. 90, 685–692.Suche in Google Scholar

Katz, L.B., Gambale, J.J., Rothenberg, P.L., Vanapalli, S.R., Vaccaro, N., Xi, L., Sarich, T.C., and Stein, P.P. (2012). Effects of JNJ-38431055, a novel GPR119 receptor agonist, in randomised, double-blind, placebo-controlled studies in subjects with type 2 diabetes. Diabetes Obes. Metab. 14, 709–716.Suche in Google Scholar

Kim, W. and Egan, J.M. (2008). The role of incretins in glucose homeostasis and diabetes treatment. Pharmaceut Rev. 60, 470–512.Suche in Google Scholar

Lan, H., Lin, H.V., Wang, C.F., Wright, M.J., Xu, S., Kang, L., Juhl, K., Hedrick, J.A., and Kowalski, T.J. (2012). Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways. Br. J. Pharmacol. 165, 2799–2807.Suche in Google Scholar

Lauffer, L.M., Iakoubov, R. and Brubaker, P.L. (2009). GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cells. Diabetes 58, 1058–1066.Suche in Google Scholar

McClenaghan, N.H., Barnett, C.R., Ah-Sing, E., Abdel-Wahab, Y.H., O’Harte, F.P.M., Yoon, Y.M., Swanston-Flatt, S.K., and Flatt, P.R. (1996). Characterisation of a novel glucose-responsive insulin-secreting cell line, BRIN BD11, produced by electrofusion. Diabetes 45, 1132–1140.Suche in Google Scholar

Miguel, J.C., Patterson, S., Abdel-Wahab, Y.H.A., Mathias, P.C. and Flatt, P.R. (2004). Time-correlation between membrane depolarization and intracellular calcium in insulin secretion BRIN-BD11 cells: studies using FLIPR. Cell Calcium 36, 43–50.Suche in Google Scholar

Moskalewski, S. (1969). Studies on the culture and transplantation of isolated islets of langerhans of the guinea pig. Proc. K. Ned. Akad. Wet. 72, 157–171.Suche in Google Scholar

Ning, Y., O’Neill, K., Lan, H., Pang, L., Shan, L.X., Hawes, B.E., and Hedrick, J.A. (2008). Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells. Br. J. Pharmacol. 155, 1056–1065.Suche in Google Scholar

Ohishi, T. and Yoshida, S. (2012). The therapeutic potential of GPR119 agonists for type 2 diabetes. Expert Opin. Investig. Drugs 21, 321–328.Suche in Google Scholar

Overton, H.A., Babbs, A.J., Doel, S.M., Fyfe, M.C.T., Gardner, L.S., Griffin, G., Jackson, H.C., Procter, M.J., Rasamison, C.M., Tang-Christensen, M., et al. (2006). Deorphanisation of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agent. Cell Metab. 3, 167–175.Suche in Google Scholar

Overton, H.A., Fyfe, M.C.T. and Reynet, C. (2008). GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity. Br. J. Pharmacol. 153, S76–S71.Suche in Google Scholar

Parker, H.E., Habib, A.M., Rogers, G.J., Gribble, F.M. and Reimann, F. (2009). Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia 52, 289–298.Suche in Google Scholar

Pavon, F.J., Serrano, A., Perez-Valero, V., Jagerovic, N., Hernandez-Folgado, L., Bermudez-Silva, F.J., Macias, M., Goya, P., and de Fonseca, F.R. (2008). Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity: effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonism, in Zucker rats. J. Neuroendocrinol. 20, 116–123.Suche in Google Scholar

Ryberg, E., Larsson, N., Sjogren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., Greasley, P.J. (2007). The orphan receptor GPR55 is a novel cannabinoid receptor. Br. J. Pharmacol. 152, 1092–1101.Suche in Google Scholar

Sakamoto, K., Inoue, H., Kawakami, S., Miyawaki, K., Miyamoto, T., Mizuta, K., and Itakura, M. (2006). Expression and distribution of GPR119 in pancreatic islets of mice and rats: predominant localization in pancreatic polypeptide-secreting PP-cells. Biochem. Biophys. Res. Commun. 351, 474–480.Suche in Google Scholar

Soga, T., Ohishi, T., Matsui, T., Saito, T., Matsumoto, M., Takasaki, J., Matsumoto, S., Kamohara, M., Hiyama, H., Yoshida, S., et al. (2005). Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem. Biophys. Res. Commun. 326, 744–751.Suche in Google Scholar

Stone, V.A., Dhayal, S., Smith, D.M., Lenaghan, C., Brocklehurst, K.G., and Morgan, N.G. (2012). The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119. Br. J. Pharmacol. 165, 2758–2770.Suche in Google Scholar

Swaminath, S. (2008). Fatty acid binding receptors and their physiological role in type 2 diabetes. Arch. Pharm. Chem. Life Sci. 341, 753–761.Suche in Google Scholar

Thabuis, C., Tissot-Favre, D., Bezelgues, J.B., Martin, J.C., Cruz-Hernandez, C., Dionisi, F., and Destaillats, F. (2008). Biological functions and metabolism of oleoylethanolamide. Lipids 43, 887–894.Suche in Google Scholar

Winzell, M.S. and Ahren, B. (2007). G-protein-coupled receptors and islet function- Implications for treatment of type 2 diabetes. Pharmacol. Ther. 116, 437–448.Suche in Google Scholar

Witkamp, R.F. (2011). Current and future drug targets in weight management. Pharmaceut. Res. 28, 1792–1818.Suche in Google Scholar

Yoshida, S., Tanaka, H., Oshima, H., Yamazaki, T., Yonetoku, T., Ohishi, T., Matsui, T., and Shibasaki, M. (2010a). AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes. Biochem. Biophys. Res. Commun. 400, 745–751.Suche in Google Scholar

Yoshida, S., Ohishi, T., Matsui, T. and Shibasaki, M. (2010b). Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion. Biochem. Biophys. Res. Commun. 400, 437–441.Suche in Google Scholar